Literature DB >> 9122230

Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

S Parkkila1, A Waheed, R S Britton, J N Feder, Z Tsuchihashi, R C Schatzman, B R Bacon, W S Sly.   

Abstract

Hereditary hemochromatosis (HH) is a common autosomal recessive disorder of iron metabolism that leads to excessive iron storage in the liver and other organs. Recently, between 83 and 100% of HH patients have been found to be homozygous for the same mutation in a novel major histocompatibility complex class I-like gene, called the HLA-H gene. The Cys-282 --> Tyr mutation in HH patients would be expected to disrupt the function of the HLA-H gene product by altering a critical disulfide bridge. As a first step in understanding the function of the HLA-H gene product, we generated an antibody to a C-terminal peptide and used it for immunolocalization of the HLA-H protein in the gastrointestinal tract of Finnish and American subjects presumed not to have HH. Although staining for the HLA-H protein was seen in some epithelial cells in every segment of the alimentary canal, its cellular and subcellular expression in the small intestine were quite distinct from those seen in other segments. In contrast to the stomach and colon, where staining was polarized and restricted to the basolateral surfaces, and in contrast to the epithelial cells of the esophagus and submucosal leukocytes, which showed nonpolarized staining around the entire plasma membrane, the staining in small intestine was mainly intracellular and perinuclear, limited to cells in deep crypts. Prior genetic evidence suggested that a defective HLA-H protein is the molecular basis of HH. Here we show that the HLA-H protein not only varies in its pattern of expression along the cranial/caudal axis of the gastrointestinal tract but that it has a unique subcellular localization in the crypts of the small intestine in proximity to the presumed sites of iron absorption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122230      PMCID: PMC20123          DOI: 10.1073/pnas.94.6.2534

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Membrane-bound carbonic anhydrase IV is expressed in the luminal plasma membrane of the human gallbladder epithelium.

Authors:  S Parkkila; A K Parkkila; T Juvonen; A Waheed; W S Sly; J Saarnio; K Kaunisto; S Kellokumpu; H Rajaniemi
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

2.  Intracellular transport blockade caused by disruption of the disulfide bridge in the third external domain of major histocompatibility complex class I antigen.

Authors:  J Miyazaki; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  pH and the recycling of transferrin during receptor-mediated endocytosis.

Authors:  A Dautry-Varsat; A Ciechanover; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

4.  A family of congenital atransferrinemia.

Authors:  N Goya; S Miyazaki; S Kodate; B Ushio
Journal:  Blood       Date:  1972-08       Impact factor: 22.113

5.  The significance of transferrin for intestinal iron absorption.

Authors:  H A Huebers; E Huebers; E Csiba; W Rummel; C A Finch
Journal:  Blood       Date:  1983-02       Impact factor: 22.113

6.  Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.

Authors:  J P Brown; R G Woodbury; C E Hart; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

7.  Hereditary hemochromatosis. Phenotypic expression of the disease.

Authors:  G E Cartwright; C Q Edwards; K Kravitz; M Skolnick; D B Amos; A Johnson; L Buskjaer
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

8.  Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence.

Authors:  T M Rose; G D Plowman; D B Teplow; W J Dreyer; K E Hellström; J P Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Genetic and phenotypic expression of hemochromatosis in Canadians.

Authors:  S T Borwein; C N Ghent; P R Flanagan; M J Chamberlain; L S Valberg
Journal:  Clin Invest Med       Date:  1983       Impact factor: 0.825

10.  Transferrin receptor and its recycling in HeLa cells.

Authors:  J D Bleil; M S Bretscher
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  39 in total

Review 1.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  The multiple roles of major histocompatibility complex class-I-like molecules in mucosal immune function.

Authors:  R S Blumberg; Y van de Wal; S Claypool; N Corazza; B Dickinson; E Nieuwenhuis; R Pitman; G Spiekermann; X Zhu; S Colgan; W I Lencer
Journal:  Acta Odontol Scand       Date:  2001-06       Impact factor: 2.331

3.  The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 4.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 5.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein.

Authors:  Chandran Ka; Gérald Le Gac; Francois-Yves Dupradeau; Jacques Rochette; Claude Férec
Journal:  Hum Genet       Date:  2005-06-18       Impact factor: 4.132

7.  Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.

Authors:  Marco Constante; Dongmei Wang; Valérie-Ann Raymond; Marc Bilodeau; Manuela M Santos
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

8.  The global burden of iron overload.

Authors:  Marnie J Wood; Richard Skoien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2009-07-29       Impact factor: 6.047

9.  Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.

Authors:  A Waheed; S Parkkila; J Saarnio; R E Fleming; X Y Zhou; S Tomatsu; R S Britton; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 10.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.